Steffen Thirstrup is a medical doctor and board-certified specialist in clinical pharmacology and therapeutics. He holds a PhD in pharmacology and has a long background in clinical internal medicine. Steffen is also an adjunct professor in pharmacotherapy at the Faculty of Health Sciences, University of Copenhagen. He previously (2004-09) worked at Danish Medicines Agency acting as the Danish member of CHMP at the European Medicines Agency (EMA) for five years including 10 months as joint CHMP- and CAT-member. In 2011 Prof. Thirstrup took on the role as Head of Division for Medicines Assessment and Clinical Trials at the Danish Medicines Agency. In March 2013, Prof Thirstrup joined the pharmaceutical consultancy company NDA Group AB as a full-time medical advisor on NDA’s regulatory advisory board. In April 2014 Prof Thirstrup was appointed as director for the Regulatory Advisory Board at NDA Regulatory Services Ltd. Since June 2022 Prof Thirstrup has been the Chief Medical Officer at the European Medicines Agency, Amsterdam, The Netherlands